Chemoinformaics analysis of Phenylacetaldehyde
| Molecular Weight | 120.151 | nRot | 2 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 15 |
| Exact Molecular Weight | 120.058 | nRing | 1 |
| Solubility: LogS | -0.53 | nHRing | 0 |
| Solubility: LogP | -1.13 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 19.4963 |
| nHD | 0 | BPOL | 8.89366 |
| QED | 0.136 |
| Synth | 4.225 |
| Natural Product Likeliness | 1.118 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.975 |
| CACO-2 | -6.163 |
| MDCK | 0.0000494 |
| BBB | 0.231 |
| PPB | 0.785634 |
| VDSS | 0.32 |
| FU | 0.393374 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.94 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.005 |
| CL | 0.744 |
| T12 | 0.616 |
| hERG | 0.006 |
| Ames | 0.034 |
| ROA | 0.259 |
| SkinSen | 0.047 |
| Carcinogencity | 0.075 |
| EI | 0.007 |
| Respiratory | 0.156 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.906779 |